Study of Denufosol Tetrasodium in Patients With Cystic Fibrosis Lung Disease

Clinical trial NCT00103714 · COMPLETED

Trial details

NCT number: NCT00103714
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2005-01-01
Primary completion: 2005-08-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.